12.21
-0.1(-0.81%)
Currency In USD
| Previous Close | 12.31 |
| Open | 12.2 |
| Day High | 12.31 |
| Day Low | 12.2 |
| 52-Week High | 14.76 |
| 52-Week Low | 7 |
| Volume | 3,866 |
| Average Volume | 5,011 |
| Market Cap | 61.52M |
| PE | 76.31 |
| EPS | 0.16 |
| Moving Average 50 Days | 13.09 |
| Moving Average 200 Days | 11.3 |
| Change | -0.1 |
If you invested $1000 in Daxor Corporation (DXR) 10 years ago, it would be worth $1,519.72 as of February 21, 2026 at a share price of $12.21. Whereas If you bought $1000 worth of Daxor Corporation (DXR) shares 5 years ago, it would be worth $992.68 as of February 21, 2026 at a share price of $12.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
GlobeNewswire Inc.
Feb 10, 2026 1:00 PM GMT
Oak Ridge, TN, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced its intention to transition its primary regulatory reporting framework from the Investment C
Daxor Corporation Announces $9 Million Registered Direct Offering
GlobeNewswire Inc.
Jan 23, 2026 1:00 PM GMT
OAK RIDGE, TN, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NasdaqCM: DXR) (“Daxor” or the “Company”) announced today that it has entered into a definitive agreement with fundamental investors for the purchase and sale of an aggregate of 76
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
GlobeNewswire Inc.
Nov 25, 2025 1:00 PM GMT
Continued Integration of ezBVA Lab Service and On-Site Analyzer Deployment Signals Accelerating Market Traction Oak Ridge, TN, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technolo